Evidence map›Paper›PMID 38655271›Full record

ArticleArchive of clinical cases2024

Active toxoplasma chorioretinitis in immunocompromised patients: a case series.

Mustafa Kayabaşı, Turhan Mammadov, Seher Köksaldı, Gül Arıkan, Süleyman Kaynak, Ali Osman Saatci

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Archive of clinical cases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Mustafa KayabaşıDepartment of Ophthalmology, Mus State Hospital, Mus, Turkey.ORCID https://orcid.org/0000-0003-2059-0696
Turhan MammadovDepartment of Ophthalmology, Dokuz Eylul University, Izmir, Turkey.ORCID https://orcid.org/0000-0002-3630-153X
Seher KöksaldıDepartment of Ophthalmology, Mus State Hospital, Mus, Turkey.ORCID https://orcid.org/0000-0001-8235-4088
Gül ArıkanDepartment of Ophthalmology, Dokuz Eylul University, Izmir, Turkey.ORCID https://orcid.org/0000-0003-0098-8250
Süleyman KaynakDepartment of Ophthalmology, Tinaztepe University, Izmir, Turkey.ORCID https://orcid.org/0000-0001-5587-7238
Ali Osman SaatciDepartment of Ophthalmology, Dokuz Eylul University, Izmir, Turkey.ORCID https://orcid.org/0000-0001-6848-7239
Dokuz Eylül University · TRIzmir University · TRSivas State Hospital · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Toxoplasma chorioretinitis (TC) can exhibit atypical features in immunocompromised patients including bilaterality, extensive spread, multifocal presentation, large areas of retinal necrosis without adjacent retinal scarring, and diffuse necrotizing retinitis resembling the viral retinitis that may cause confusion in the differential diagnosis. The aim of this study was to present the clinical features of four eyes of three immunocompromised patients with active toxoplasma chorioretinitis. Two of the patients were female and one, male. Two patients had hematological malignancies and the remaining patient was under adalimumab treatment for ankylosing spondylitis. Visual complaints began 10 days to four months prior to TC diagnosis. All four eyes had mild-to-moderate anterior chamber cells together with severe vitritis on slit-lamp examination while there were solitary chorioretinitis lesions on fundoscopy. Despite all patients were negative for anti-toxoplasma immunoglobulin M, all were positive for immunoglobulin G. All three patients were successfully treated with a combined treatment of systemic and intravitreal anti-toxoplasmic drugs. Clinicians should be cautious for the possible toxoplasma chorioretinitis besides the other infectious entities when a new uveitis episode is detected in an immunosuppressed patient in order to avoid misdiagnosis and thereby wrong treatment.

Indexed as

Anti-toxoplasmic therapyimmunosuppressionocular toxoplasmosistoxoplasma chorioretinitisuveitis

Identifiers

PMID38655271
PMCPMC11034477
OpenAlexW4395466630

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.